Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer-Reference-Cited by-同舟云学术

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published:2010-01-26 Issue:3 Volume:70 Page:875-882
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Galanis Evanthia,Hartmann Lynn C.,Cliby William A.,Long Harry J.,Peethambaram Prema P.,Barrette Brigitte A.,Kaur Judith S.,Haluska Paul J.,Aderca Ileana,Zollman Paula J.,Sloan Jeff A.,Keeney Gary,Atherton Pamela J.,Podratz Karl C.,Dowdy Sean C.,Stanhope C. Robert,Wilson Timothy O.,Federspiel Mark J.,Peng Kah-Whye,Russell Stephen J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring treatment options in cancer: tumor treatment strategies;Signal Transduction and Targeted Therapy;2024-07-17

2. New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review;Frontiers in Pharmacology;2024-06-14

3. Functional remodeling of intraperitoneal macrophages by oncolytic adenovirus restores anti-tumor immunity for peritoneal metastasis of gastric cancer;Molecular Therapy: Oncology;2024-06

4. Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract;Science Advances;2024-05-31

5. Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells;Molecular Medicine Reports;2024-05-15